- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
- 10-K Annual report
- 10.39 Summary of Cash Bonus Awards for Fiscal Year Ended December 31, 2004
- 10.40 Summary of Certain Stock Option Grants
- 21.1 Subsidiaries of the Registrant
- 23.1 Consent of Pricewaterhousecoopers LLP
- 31.1 Certifications of Chief Executive Officer Pursuant to Exchange Act Rules
- 31.2 Certifications of Chief Financial Officer Pursuant to Exchange Act Rules
- 32 Certification of CEO and CFO Pursuant to 18 U.s.c. Section 1350
EXHIBIT 10.40
Summary of Stock Option Grants made to Named Executive Officers
On February 22, 2005, the Compensation Committee of the Board of Directors approved the following grant of options to purchase shares of Align common stock to certain of our employees (including each of our named executive officers). Except for the vesting schedule set forth below, the material terms of each of the stock option agreements is identical to the form of option agreement filed with our Form 10-Q for the quarter ended September 30, 2004. The following table sets forth information regarding the option grants to each of our named executive officers:
Name | Number of Securities Underlying Options Granted | Exercise Price | |||
Thomas M. Prescott, President, Chief Executive Officer and Director | 150,000 | $ | 7.35 | ||
Eldon M. Bullington, Vice President, Finance and Chief Financial Officer | 125,000 | $ | 7.35 | ||
David S. Thrower, Vice President, Global Marketing | 120,000 | $ | 7.35 | ||
Len M. Hedge, Vice President, Manufacturing | 120,000 | $ | 7.35 | ||
Roger E. George Vice President, Legal and Corporate Affairs, and General Counsel and Corporate Secretary | 115,000 | $ | 7.35 |
Each of the above options vest in accordance with the following schedule: 25% of the shares subject to the option were vested and exercisable on the date of grant, and 2.083% of the shares subject to the option become vested and exercisable each month thereafter.